Asensus Surgical, Inc.
Asensus Surgical, Inc. (ASXC) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
asxc · stock forecast · 2 analysts (3M) · FMP · updated Apr 25, 2025
Analyst Rating & Consensus
Based on 2 Wall Street analysts in the past 3 months
Hold
2 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$1.50
Consensus
$1.50
+331.2% upside
Low
$1.50
Median: $1.5 · Last Close: $0.35
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.34 | ↓ 1.37% |
1-day model range: $0.34–$0.35. Peak: $0.35 (-1.37%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ASXC · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-05-16 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2024-04-04 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2024-03-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-11-16 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2023-11-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-08-22 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2023-08-21 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2023-08-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-08-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-05-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Asensus Surgical, Inc. (ASXC) stock. Of the recent 19 rating actions, 0 were upgrades and 2 were downgrades. 2 analysts currently cover ASXC.
Analyst Recommendation Trends
ASXC analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$12M
↓ 76.5% YoY
Revenue Next Year
$22M
↑ 81.7% YoY
EPS This Year
$-0.24
EPS Next Year
$-0.19
↓ 20.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast ASXC EPS of $-0.24 for the current fiscal year, based on estimates from 1 analysts. The ASXC revenue forecast is $12M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ASXC stock forecast is supported by two independent data sources: analyst consensus ratings from 2 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ASXC price target is $1.50 (+331.2% upside), with an analyst consensus of Hold.
The ASXC short-term stock prediction for tomorrow is $0.34 (-1.37%).
Asensus Surgical, Inc. trades on AMEX under the ticker ASXC. The ASXC stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 0% of covering analysts.
Frequently asked questions
ASXC forecast · 8 questionsAccording to 2 Wall Street analysts, the average 12-month ASXC price target is $1.50, with a high forecast of $1.50 and a low of $1.50. The median price target is shown in the chart above when available. This implies +331.2% potential upside from the current price of $0.35.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.